• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

光化性角化病面积和严重指数(AKASI)与鳞状细胞癌的发生率相关。

Actinic keratosis area and severity index (AKASI) is associated with the incidence of squamous cell carcinoma.

机构信息

Department of Dermatology, Venereology and Allergology, Ruhr-University, Bochum, Germany.

Department of Dermatology, Monklands Hospital, Lanarkshire, UK.

出版信息

J Eur Acad Dermatol Venereol. 2018 May;32(5):752-756. doi: 10.1111/jdv.14682. Epub 2017 Dec 18.

DOI:10.1111/jdv.14682
PMID:29117441
Abstract

BACKGROUND

Actinic keratoses (AKs) are commonly diagnosed clinically. Actinic keratosis area and severity index (AKASI) is a new easy-to-use tool to assess the severity of AKs on the head.

OBJECTIVES

To determine the association between chronically UV-induced tumours such as basal cell carcinomas (BCC) or squamous cell carcinomas (SCC) and AKASI.

METHODS

We performed a retrospective analysis of patients who had undergone oncological surgery due to UV-induced tumours and who were assessed for AKASI and Physician's global assessment (PGA) prior to surgery. Statistical analysis was performed to evaluate correlation between AKASI, PGA and invasive carcinomas.

RESULTS

Of the 210 patients included, 26 patients had histologically diagnosed SCCs and presented with a median (range) AKASI of 6.9 (0-13.0) and PGA of 2 (0-4). In contrast, the 82 patients with BCCs showed a median (range) AKASI of 3.3 (0-15.2) and PGA of 1 (0-4). The Mann-Whitney U-test showed significant differences (P = 0.0018) between AKASI of patients with SCC and BCC. In addition, we found a significantly higher AKASI in patients with SCC compared to patients with non-invasive lesions like AK and Bowen disease (BD) (P = 0.0275). Spearman's coefficient of rank correlation between AKASI and PGA indicates that these measures of AK severity were strongly correlated (P < 0.0001; r = 0.90; 95% CI 0.865-0.920).

CONCLUSIONS

Patients with SCC show significantly higher AKASI than patients with BCC or patients without invasive tumours. Hence, AKASI may be used to stratify risk for developing invasive SCC.

摘要

背景

光化性角化病(AK)通常通过临床诊断。光化性角化病面积和严重指数(AKASI)是一种新的用于评估头部 AK 严重程度的简单易用的工具。

目的

确定慢性紫外线诱导肿瘤(如基底细胞癌(BCC)或鳞状细胞癌(SCC))与 AKASI 之间的关联。

方法

我们对因紫外线诱导肿瘤而接受肿瘤手术的患者进行了回顾性分析,并在手术前评估了 AKASI 和医生整体评估(PGA)。进行了统计分析,以评估 AKASI、PGA 和浸润性癌之间的相关性。

结果

在 210 例患者中,26 例患者组织学诊断为 SCC,中位(范围)AKASI 为 6.9(0-13.0)和 PGA 为 2(0-4)。相比之下,82 例 BCC 患者的中位(范围)AKASI 为 3.3(0-15.2)和 PGA 为 1(0-4)。Mann-Whitney U 检验显示 SCC 和 BCC 患者的 AKASI 存在显著差异(P=0.0018)。此外,我们发现 SCC 患者的 AKASI 明显高于 AK 和 Bowen 病(BD)等非浸润性病变患者(P=0.0275)。AKASI 和 PGA 之间的 Spearman 秩相关系数表明,这些 AK 严重程度的测量值具有很强的相关性(P<0.0001;r=0.90;95%置信区间 0.865-0.920)。

结论

SCC 患者的 AKASI 明显高于 BCC 或无浸润性肿瘤患者。因此,AKASI 可用于分层 SCC 浸润的风险。

相似文献

1
Actinic keratosis area and severity index (AKASI) is associated with the incidence of squamous cell carcinoma.光化性角化病面积和严重指数(AKASI)与鳞状细胞癌的发生率相关。
J Eur Acad Dermatol Venereol. 2018 May;32(5):752-756. doi: 10.1111/jdv.14682. Epub 2017 Dec 18.
2
A proposed scoring system for assessing the severity of actinic keratosis on the head: actinic keratosis area and severity index.一种用于评估头部光化性角化病严重程度的评分系统:光化性角化病面积和严重指数。
J Eur Acad Dermatol Venereol. 2017 Aug;31(8):1295-1302. doi: 10.1111/jdv.14267. Epub 2017 May 3.
3
Cyclin A and beta-catenin expression in actinic keratosis, Bowen's disease and invasive squamous cell carcinoma of the skin.细胞周期蛋白A和β-连环蛋白在光化性角化病、鲍恩病及皮肤浸润性鳞状细胞癌中的表达
Br J Dermatol. 2005 Dec;153(6):1166-75. doi: 10.1111/j.1365-2133.2005.06898.x.
4
Photodynamic therapy leads to significant improvement of actinic keratosis area and severity index (AKASI).光动力疗法可显著改善光化性角化病面积和严重指数(AKASI)。
Photodiagnosis Photodyn Ther. 2018 Mar;21:66-70. doi: 10.1016/j.pdpdt.2017.10.007. Epub 2017 Oct 16.
5
Nonmelanoma skin cancer in Japanese ethnic Hawaiians in Kauai, Hawaii: an incidence report.夏威夷考艾岛日本裔夏威夷人的非黑色素瘤皮肤癌:发病率报告。
J Am Acad Dermatol. 1995 Sep;33(3):422-6. doi: 10.1016/0190-9622(95)91387-4.
6
Diclofenac Sodium 3% in Hyaluronic Acid 2.5% Gel Significantly Diminishes the Actinic Keratosis Area and Severity Index.双氯芬酸钠 3%联合透明质酸 2.5%凝胶显著减少光化性角化病面积和严重指数。
Skin Pharmacol Physiol. 2018;31(4):206-211. doi: 10.1159/000488248. Epub 2018 May 23.
7
The occurrence of non-melanoma malignant skin lesions and non-cutaneous squamous-cell carcinoma among metastatic melanoma patients: an observational cohort study in Denmark.转移性黑色素瘤患者中非黑色素瘤恶性皮肤病变和非皮肤鳞状细胞癌的发生情况:丹麦的一项观察性队列研究
BMC Cancer. 2016 May 3;16:295. doi: 10.1186/s12885-016-2315-0.
8
Premalignant lesions, basal cell carcinoma and melanoma in patients with cutaneous squamous cell carcinoma.皮肤鳞状细胞癌患者的癌前病变、基底细胞癌和黑色素瘤。
Arch Dermatol Res. 2021 Dec;313(10):879-884. doi: 10.1007/s00403-020-02114-w. Epub 2020 Aug 9.
9
Actinic keratoses: Natural history and risk of malignant transformation in the Veterans Affairs Topical Tretinoin Chemoprevention Trial.光化性角化病:退伍军人事务部外用维甲酸化学预防试验中的自然史及恶性转化风险
Cancer. 2009 Jun 1;115(11):2523-30. doi: 10.1002/cncr.24284.
10
Cutaneous squamous cell carcinomas are associated with basal proliferating actinic keratoses.皮肤鳞状细胞癌与基底细胞增生性光化性角化病有关。
Br J Dermatol. 2019 Apr;180(4):916-921. doi: 10.1111/bjd.16536. Epub 2018 Jun 29.

引用本文的文献

1
The Role of HPV in the Development of Cutaneous Squamous Cell Carcinoma-Friend or Foe?人乳头瘤病毒在皮肤鳞状细胞癌发生发展中的作用——是友是敌?
Cancers (Basel). 2025 Mar 31;17(7):1195. doi: 10.3390/cancers17071195.
2
Epidemiology and Risk Factors of Actinic Keratosis. What is New for The Management for Sun-Damaged Skin.光化性角化病的流行病学与危险因素。日光损伤皮肤管理的新进展。
Dermatol Pract Concept. 2024 Sep 1;14(3 S1):e2024146S. doi: 10.5826/dpc.1403S1a146S.
3
An Update on Non-Invasive Skin Imaging Techniques in Actinic Keratosis-A Narrative Review.
光化性角化病的无创性皮肤成像技术更新:综述
Medicina (Kaunas). 2024 Jun 26;60(7):1043. doi: 10.3390/medicina60071043.
4
Understanding Active Photoprotection: DNA-Repair Enzymes and Antioxidants.了解主动光防护:DNA修复酶与抗氧化剂
Life (Basel). 2024 Jun 28;14(7):822. doi: 10.3390/life14070822.
5
Actinic Keratoses: A Prospective Pilot Study on a Novel Formulation of 4% 5-Fluorouracil Cream and a Review of Other Current Topical Treatment Options.光化性角化病:一项关于4% 5-氟尿嘧啶乳膏新配方的前瞻性初步研究及其他当前局部治疗选择的综述
Cancers (Basel). 2023 May 28;15(11):2956. doi: 10.3390/cancers15112956.
6
AKASI and Near-Infrared Spectroscopy in the combined effectiveness evaluation of an actinic keratoses preventive product in immunocompetent and immunocompromised patients.AKASI和近红外光谱在免疫功能正常和免疫功能低下患者中对一种光化性角化病预防产品的联合有效性评估
Front Med (Lausanne). 2022 Sep 7;9:987696. doi: 10.3389/fmed.2022.987696. eCollection 2022.
7
Comparison of Actinic Keratosis and Severity Index with Physician Global Assessment and Total Lesion Count and the Ability to Predict Skin Cancer.光化性角化病与严重程度指数与医生整体评估及总皮损计数的比较以及预测皮肤癌的能力。
Dermatol Pract Concept. 2022 Jan 1;12(1):e2022031. doi: 10.5826/dpc.1201a31. eCollection 2022 Feb.
8
Topical Pharmacotherapy for Actinic Keratoses in Older Adults.老年人光化性角化病的局部药物治疗。
Drugs Aging. 2022 Feb;39(2):143-152. doi: 10.1007/s40266-022-00919-0. Epub 2022 Feb 14.
9
Method of Assessing Skin Cancerization and Keratoses (MASCK™): development and photographic validation in multiple anatomical sites of a novel assessment tool intended for clinical evaluation of patients with extensive skin field cancerization.皮肤癌化和角化评估方法(MASCK™):一种用于评估广泛皮肤癌化患者的新型临床评估工具,在多个解剖部位的开发和摄影验证。
Clin Exp Dermatol. 2022 Jun;47(6):1144-1153. doi: 10.1111/ced.15136. Epub 2022 Mar 22.
10
How to Assess the Efficacy of Interventions for Actinic Keratosis? A Review with a Focus on Long-Term Results.如何评估光化性角化病干预措施的疗效?一项聚焦长期结果的综述
J Clin Med. 2021 Oct 15;10(20):4736. doi: 10.3390/jcm10204736.